Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock At Cost [Member]
Accumulated Other Comprehensive Loss [Member]
Retained Earnings (Accumulated Deficit) [Member]
Total
Balance at Jan. 30, 2021 $ 33 $ 346,495 $ (230,169) $ (2,007) $ (112,863) $ 1,489
Balance (in shares) at Jan. 30, 2021 3,337   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (1,335) (1,335)
Issuance of warrants $ 1 0 $ (1) 0 0 0
Issuance of warrants (in shares) 138   0      
Sale of shares, net of expenses $ 4 12,227 $ 0 0 0 12,231
Sale of shares, net of expenses (in shares) 417   0      
Exercise of stock options $ 0 51 $ 0 0 0 51
Exercise of stock options (in shares) 2   0      
Common stock issued- Director grants $ 1 184 $ 0 0 0 185
Common stock issued- Director (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 59 $ 0 0 0 59
Balance at Jul. 31, 2021 $ 39 359,016 $ (230,170) (2,007) (114,198) 12,680
Balance (in shares) at Jul. 31, 2021 3,903   (1,410)      
Balance at May. 01, 2021 $ 39 358,749 $ (230,170) (2,007) (114,280) 12,332
Balance (in shares) at May. 01, 2021 3,889   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 82 82
Other comprehensive income 0 0 0 0 0 0
Issuance of warrants 0 0 0 0 0 0
Vested restricted shares $ 0 0 $ 0 0 0 0
Vested restricted shares (in shares) 3   0      
Exercise of stock options $ 0 51 $ 0 0 0 51
Exercise of stock options (in shares) 2          
Common stock issued- Director grants $ 1 184 $ 0 0 0 184
Common stock issued- Director (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 32 $ 0 0 0 32
Balance at Jul. 31, 2021 $ 39 359,016 $ (230,170) (2,007) (114,198) 12,680
Balance (in shares) at Jul. 31, 2021 3,903   (1,410)      
Balance at Jan. 29, 2022 $ 39 359,220 $ (230,170) (910) (120,894) 7,285
Balance (in shares) at Jan. 29, 2022 3,903   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (8,846) (8,846)
Issuance of shares, net of expenses $ 0 (97,127) $ 104,264 0 0 7,137
Issuance of shares, net of expenses (in shares) 0   638      
Issuance of warrants $ 0 1,518 $ 0 0 0 1,518
Issuance of warrants (in shares) 0   0      
Exercise of stock options $ 0 0 $ 0 0 0 0
Exercise of stock options (in shares) 0   0      
Common stock issued- Director grants $ 0 41 $ 0 0 0 41
Common stock issued- Director (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 71 $ 0 0 0 71
Balance at Jul. 30, 2022 $ 39 263,723 $ (125,906) (910) (129,740) 7,206
Balance (in shares) at Jul. 30, 2022 3,912   (772)      
Balance at Apr. 30, 2022 $ 39 360,738 $ (230,170) (910) (125,324) 4,375
Balance (in shares) at Apr. 30, 2022 3,903   (1,410)      
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 0 0 $ 0 0 (4,416) (4,416)
Issuance of shares, net of expenses $ 0 (97,127) $ 104,264 0 0 7,137
Issuance of shares, net of expenses (in shares) 0   638      
Common stock issued- Director grants $ 0 41 $ 0 0 0 41
Common stock issued- Director (in shares) 9   0      
Amortization of unearned compensation/restricted stock amortization $ 0 71 $ 0 0 0 71
Balance at Jul. 30, 2022 $ 39 $ 263,723 $ (125,906) $ (910) $ (129,740) $ 7,206
Balance (in shares) at Jul. 30, 2022 3,912   (772)